Answers are grounded in this paper and cite their sources.
The occurrence of hepatic steatosis in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency has been well documented. Fat accumulation, resulting from the metabolic disturbances associated with an energy crisis, is believed to occur rapidly at onset. On resolution of the energy crisis, however, the course of hepatic steatosis and the associated metabolic disturbances is not well known. In this report, the course of hepatic steatosis and its correlation to plasma carnitine levels is explored in one patient. Hepatic fat content was determined by a novel MRI technique, requiring only a few seconds to perform. CASE REPORT TR was a 7-month-old boy in previously good health with acute onset of lethargy and poor appetite. During the next 24 hours, the child became limp and pale and experienced frequent vomiting episodes that caused dehydration. On arrival in the emergency room, the child appeared pale and flaccid. He was unable to focus and had a minimal response to pain. The physical examination revealed height and weight at the 10th percentile and liver edge located 4 to 5 cm below the costal margin at the right midclavicular line. Results of initial laboratory studies were remarkable for blood glucose of less than 20 mg/dl; serum Na+, 140 mEq/l; K+, 4.5 mEq/l; Cl-, 110 mEq/l; HCO3-, 11 mEq/l; total bilirubin, 0.3 mg/dl; serum glutamic-oxaloacetic transaminase, 45 IU/l; serum glutamic-pyruvic transaminase, 38 IU/l; γ-glutamyl transpeptidase, 9 IU/l; lactic acid, 1.1 mmol/l; and serum ammonia, 46 µmol/l. A urinalysis revealed trace ketones. The child was administered intravenous dextrose solution and was admitted for further evaluation of hypoglycemia, metabolic acidosis, and hepatomegaly. The child's blood glucose normalized rapidly and his overall condition improved steadily during the next few days, with diminished vomiting and a return to normal mental status. Diagnostic studies, including urinalysis for organic acids, revealed large increases in adipic, suberic, and sebacic acid concentrations, consistent with a primary disorder of fatty acid oxidation. The ratio of urinary carnitine ester to free carnitine was 18:1 (normal,<4:1), suggestive of organic aciduria. Plasma total carnitine level was 59µmol/l (normal, 47 ± 11 µmol/L; free, 35 µmol/l[normal, 38 ± 11 µmol/l] ester, 44 µmol/l[normal, 9± 5 µmol/L]). The plasma acylcarnitine profile demonstrated increased concentrations of octanoyl and decenoyl carnitine, with diminished acetylcarnitine, consistent with MCAD deficiency. The DNA testing for common single-point mutation (A985G) in the MCAD gene confirmed that the subject was homozygous for the disorder. The child was discharged receiving L-carnitine supplementation (30 mg/kg three times daily) and instructed to fast no longer than 8 hours. After 2 months, he remains asymptomatic, and his liver size has normalized. On days 1, 23, and 58 after initial examination, the subject's hepatic fat fraction was assessed by magnetic resonance imaging (MRI) on a 1.5-T MRI system (GE Signa; General Electric Medical Systems, Waukeesha, WI, U.S.A.), using a modification of the Dixon method described by Fishbein et al. (1) Quantification of hepatic fat content using MRI is made possible by the characteristic differences between fat and water in resonant frequencies. Signal intensity is at a maximum when water and fat signals are "in-phase" and are at a minimum when water and fat are"out-of-phase." Magnetic resonance images processed from in-phase (+water,+fat) and out-of-phase (+water, -fat) signals are used to derive the fat fraction. The patient was positioned supine inside the body coil at a midpoint level between the umbilicus and the xiphoid tip. One-centimeter axial slices of the liver were obtained. Scan parameters included relaxation time or TR, 9.3 msec(in phase) and 7.3 msec (out of phase); echo time or TE, 4.2 msec (in phase) and 2.1 msec (out of phase); flip angle or α, 30°; slice thickness, 10 mm; field of view, 32 × 16 cm; matrix size, 256× 128; and number of excitations or NEX, 8. Acquisition times for a single slice were 5 seconds and 4 seconds for in-phase and out-of-phase scans, respectively. Pixel signal intensities from in-phase and out-of-phase images were obtained from selected regions of interest, using an adjustable-shaped cursor. Region of interest selection within the liver was based on the presence of maximal parenchyma without contamination of blood vessels, motion artifacts, or partial volume effects. Several regions of interest were obtained throughout the liver and were averaged to determine fat fraction. The initial study was performed in conjunction with a head MRI using intravenous thiopental. The subsequent studies were performed without premedication. Serial MRI examinations, originating at the time of the patient's energy crisis, revealed a regression of hepatic fat content for a period of several weeks (Figs. 1 and 2). Approximately 2 months after the energy crisis, the hepatic fat content had normalized.FIG. 1: Hepatic magnetic resonance images obtained during the crisis episode and 2 months later. Signal differences between in-phase (+water, -fat) and out-of-phase (+water, -fat) were used to determined hepatic fat content. During acute crisis: (A) in-phase scan, (B) out-of-phase scan. Large signal drop is indicative of heavy fatty infiltrate. Two months later: (C) in-phase scan,(D) out-of-phase scan. Motion artifact is present. Decreased signal drop from initial scans is indicative of regression of hepatic fat.FIG. 2: The regression of hepatic steatosis after acute crisis in MCAD deficiency. Carnitine supplementation was initiated immediately after the crisis period. Carnitine profiles were obtained during the acute episode (plasma and urine) and were repeated 2 months later(plasma).DISCUSSION MCAD deficiency is the most common hereditary disease of fatty acid oxidation and one of the most common inborn errors of metabolism (1:15,000). The age range of symptomatic children is 2 months to 4 years. One of the clinical manifestations of MCAD deficiency is somnolence that can progress to lethargy and coma. These symptoms are often induced by a sentinel or proximate illness and prolonged fasting. Sudden infant death syndrome (SIDS) has been linked to this disorder in 1% to 3% of cases. Routine laboratory studies for the investigation of a disorder of fatty acid oxidation include urinary ketones and blood glucose. Hypoketotic hypoglycemia, as seen in this case, is classically present in disorders of fatty acid oxidation. The presence of hypocarnitinemia, with reversed, high esterified:free carnitine ratio is also common in fatty acid oxidation disturbances. Although the total carnitine level in this patient was normal during the crisis period, the excess in esterified carnitine was striking and most likely represented octanylcarnitine, as was supported by the acylcarnitine profile. The main urinary metabolites found on organic acid screening in this disorder include increased C6-C10 dicarboxylic acids(adipic, suberic, sebacic) produced by alternate omega fatty acid oxidation during the acute crisis or with fasting. MCAD deficiency may also be identified by increased plasma octanylcarnitine using fast-atom bombardment-mass spectroscopy (FAB-MS), urinary hexanyl, and phenylproprionyl glycine excretion on radioisotopic exchange gas chromatography and genotyping to evaluate for the presence of the A985G single-point mutation. The presence of hepatic steatosis in patients with MCAD deficiency has been well documented in post-mortem examinations of patients with sudden death and in a few patients, during acute crisis. In fact, the presence of hepatic steatosis in any child who dies suddenly and in the appropriate age group, despite the absence of other abnormalities seen at autopsy, is sufficient evidence to pursue a metabolic disorder, especially one of fatty acid oxidation. The assessment of fatty liver using radiographic techniques has involved standard MRI (magnetic resonance imaging) techniques (i.e., spin- gradient echo), magnetic resonance spectroscopy, and computed tomography (CT) (2-9). These methods have been impractical for the study of children because of their lengthy scan times, their reliance on compliance of the patient, or their ionizing radiation. Conscious sedation would usually be required to perform such a study. A faster technique to quantitate hepatic fat content has been developed using (fast gradient echo) MRI. The scan times are sufficiently brief (4 seconds and 5 seconds) to be completed within a single respiratory cycle in a school-aged child, but the patient is not required to hold his or her breath for satisfactory results. The current case involving a child with MCAD deficiency is the first in which the presence of fatty infiltration of the liver was determined in a noninvasive manner during the energy crisis and during resolution in the next few months. Magnetic resonance imaging should be helpful in identifying hepatic steatosis in other childhood metabolic disorders. In some disorders, including nonalcoholic steatohepatitis, a liver biopsy may be averted using this technique. In other instances, such as valproate hepatotoxicity, an alternative means of drug monitoring is introduced. Fat accumulation in MCAD deficiency is believed to be most prominent during the crisis period and to lessen considerably on resolution(10,11). On ultrastructural studies, the mechanism of lipid accumulation may differ during acute and chronic conditions (12). During the crisis period, macrovesicular fat deposition occurs, and afterward, microvesicular fat is more prominent. The striking temporal correlation between the metabolic crisis and acute hepatomegaly has been described previously by Slonim et al.(13) In the current study, the normalization of hepatic fat fractions from 36% during the acute crisis to 15% at 3 weeks and 3%(normal) 8 weeks after the crisis provide further evidence for the transient nature of hepatic steatosis and hepatomegaly in this disorder. The mechanism of hepatic fat accumulation in MCAD deficiency remains unclear. In other case studies, no obvious correlation was established between total carnitine levels and hepatomegaly (10). In the currently reported case, the initial plasma carnitine levels obtained during the crisis demonstrated normal plasma and urinary total carnitine concentrations but a markedly abnormal profile of increased acylcarnitine excretion. After oral carnitine supplementation, the total carnitine level remained stable. The normalization of the free:esterified ratio probably occurred because of clearance of the unmetabolized medium-chain coenzyme A esters from the plasma related to a lower renal threshold for the esterified carnitine moieties (14). Alternatively, the metabolic crisis itself, as suggested by results of fasting studies, completely disrupted mitochondrial fatty acid metabolism and lipid transport within the cell and resulted in the dramatic 10-fold increase in lipid content and the prolonged recovery phase. Based on our observations of this patient, we favor the latter hypothesis.
No takes yet. Share an insight, caveat, or question.
Fishbein et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: